Report
Christophe-Raphaël Ganet

Bastide : H1 2023-24 results: revenues hold up well in persistently inflationary environment

>H1 underlying operating profit slightly shy of our forecasts - Bastide published its H1 2023-24 results, reporting EBITDA of € 53.6m, up 7.5% (margin: 20.2% vs 20% in H1 2022-23). The underlying operating profit came in at € 21.9m (+2.1%) and net profit at € 2.4m (-7.7%), impacted by 1/ a 150bp increase in personnel costs, 2/ a net loss of € 1.2m related to a discontinued business (disposal of Livramedom), 3/ restructuring costs of € 0.4m, 4/ an increase in financial...
Underlying
Bastide Le Confort Medical SA

Bastide le Confort Medical is a holding company. Through its subsidiaries, Co. is engaged in the home health care industry. Co. retails and rents medical equipment and provides medical services. Products include breathing apparatus, orthopedic shoes, walking aids and wheelchairs, home appliances and furniture adapted to the needs of the lesser able, with the recent addition of equipment related to perfusion and nutrition. Co. operates through a number of outlets concentrated mainly in the South of France, offering advice and information to customers along with the provision and maintenance of medical equipment.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Christophe-Raphaël Ganet

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch